Cleerly ISCHEMIA vs EchoGo Pro
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a detailed, non-invasive assessment of coronary artery disease leveraging CCTA scans. This tool is ideal for physicians needing vessel-level ischemia likelihood, comprehensive plaque characterization, and 3D anatomical models to personalize diagnosis and treatment plans. It provides an in-depth view beyond just stenosis, incorporating functional estimations like non-invasive FFR.
View Cleerly ISCHEMIA →Choose EchoGo Pro if…
Choose EchoGo Pro if your primary need is automated, rapid analysis of stress echocardiography to diagnose coronary artery disease. This cloud-based solution is best suited for cardiology practices and echo labs seeking near-instant, accurate reports and improved diagnostic efficiency for functional assessments. It offers a vendor-neutral, seamless integration for quick identification of CAD without extensive software installation.
View EchoGo Pro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | EchoGo Pro |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | Web-based solution | Cloud-based (SaaS) |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoGo ProEchoGo Pro (Tool B) explicitly highlights its SaaS model, requiring no software installation or extensive training, and its vendor-neutral compatibility with any PACS system. Cleerly ISCHEMIA (Tool A) mentions a web-based platform but also a 'Cleerly Proxy' for data transfer, which might imply a slightly more involved setup.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA (Tool A) offers a more comprehensive and detailed clinical assessment by providing non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood, and detailed coronary plaque characterization (volume, type, location) from CCTA scans. While EchoGo Pro (Tool B) automates stress echo analysis for CAD diagnosis, Tool A provides a deeper, multi-faceted view of coronary disease pathology.
Pricing & Value
Cleerly ISCHEMIACleerly ISCHEMIA (Tool A) has a significant advantage with the establishment of a new Category I CPTu00ae code (75580) specifically for its non-invasive FFR estimation, effective January 1, 2024, which provides a clear pathway for reimbursement. While EchoGo Pro (Tool B) mentions reimbursement codes for related products, it doesn't specify a direct Category I CPT code for its core offering, making its reimbursement path less transparent.
Enterprise Readiness
EchoGo ProBoth tools are FDA-cleared, HIPAA compliant, and have BAAs. However, EchoGo Pro (Tool B) emphasizes its vendor-neutral system, compatibility with any PACS, and seamless integration with existing clinical workflows (DICOM, HL7), indicating broader and potentially easier adoption within diverse enterprise IT environments. Tool A mentions integration with PowerScribe via API, which is good, but Tool B's claims suggest more universal compatibility.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA (Tool A) demonstrates greater innovation by providing non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA scans, moving beyond traditional anatomical assessment. This offers a novel approach to understanding both the anatomical and functional significance of coronary artery disease. EchoGo Pro (Tool B) focuses on automating existing stress echocardiography analysis, which is valuable but less of a paradigm shift.
Support & Docs
EchoGo ProUltromics, the company behind EchoGo Pro (Tool B), explicitly lists 'Customer Support' and mentions 'dedicated support and customer success teams' on its website, along with various resources like clinical dossiers and webinars. While Cleerly (Tool A) provides documentation related to billing and coverage, it does not explicitly detail general customer support channels or comprehensive technical documentation in the same way.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | EchoGo Pro |
|---|---|---|
| Name | Cleerly ISCHEMIA | EchoGo Pro |
| Company | Cleerly | Ultromics |
| Tagline | AI-Powered Precision for Non-Invasive Ischemia Detection | AI-powered echocardiography solutions for enhanced cardiac diagnosis |
| Primary Imaging Modality Analyzed | CCTA scans | Stress echocardiography |
| Key Diagnostic Focus | Non-invasive determination of likelihood of coronary artery ischemia at a vessel level; coronary plaque characterization; stenosis severity assessment | Automated identification of coronary artery disease (CAD) |
| Key Output/Report Type | Comprehensive interactive web-based reports; 3D digital models of coronary arteries | Near-instant, accurate, comprehensive reports |
| Integration Capabilities | Integration with PowerScribe via API | Vendor-neutral system, compatible with any PACS; seamless integration with existing clinical workflows (DICOM, HL7) |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and EchoGo Pro.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or EchoGo Pro
Backers
Who funded each tool's parent company.